SEC Form EFFECT filed by Can B Corp.
$CANB
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 24, 2025 |
| Accession Number: | 0001493152-25-001887 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 24, 2025 |
| Accession Number: | 0001493152-25-001887 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
15-12G - Can B Corp (0001509957) (Filer)
NT 10-K - Can B Corp (0001509957) (Filer)
EFFECT - Can B Corp (0001509957) (Filer)
Primary Focus on Protecting and Commercializing Cannabis Patents HICKSVILLE, N.Y., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Can B Corp. (OTCQB:CANB) ("Can B" or the "Company") today announced that it has implemented a reorganization in which a new holding company, Nascent Pharma Holdings, Inc., has become the publicly-traded parent of Can B and its subsidiaries. As a result of the reorganization, existing shares of Can B stock have been automatically converted, on a one-for-one basis, into shares of common stock of Nascent Pharma Holdings, Inc. The Board and executive officers of Can B will continue in the same roles at Nascent Pharma Holdings, Inc. In March 2024, Can B announced that
HICKSVILLE, NY, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and durable medical devices, is pleased to announce it has successfully completed a corporate debt restructuring. Through the restructuring, Can B raised $1.55 million of new capital and extended previously due notes payable totaling $7.0 million to September 1, 2023, and December 31, 2024. Specifically, three Promissory Notes issued to three funds in early 2022 and three Promissory Notes issued to three private investors in late 2022 were restructur
NEW YORK , July 26, 2022 /PRNewswire/ -- Forever Brands, a wholly owned subsidiary of ZA Group, Inc (OTCQB:ZAAG), has signed a manufacturing agreement with Imbibe Wellness Solutions, LLC a wholly owned subsidiary of Can B Corp (OTCQB:CANB) for the production of a new brand of Plant Based Super Food, Longevity by Brooke Burke Body TM. Can B develops consumer products at their State-of-the-Art-Research & Development facility in Lacey, WA. The Company develops, produces and test all products under the highest industry standards with independent lab testing. Can B issues Certificates of Analysis for all products! "This is a major milestone in our plan for launching Longevity on schedule. Securin
SC 13G/A - Can B Corp (0001509957) (Subject)
SC 13G/A - Can B Corp (0001509957) (Subject)
SC 13G/A - Can B Corp (0001509957) (Subject)